Study on Continuous Monitoring Post-Pulmonary Endarterectomy in CTEPH
Phase III
Pulmonology / Chronic Thromboembolic Pulmonary Hypertension
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
Adoption of continuous monitoring may enhance postoperative care and recovery strategies, potentially influencing treatment protocols and competitive positioning for devices like CardioMEMS™ in CTEPH management.
Why it matters
The CTEPH-CardioMEMS study introduces a critical shift in postoperative management for chronic thromboembolic pulmonary hypertension (CTEPH) by evaluating continuous haemodynamic monitoring. This approach addresses a significant gap in current practices, where intermittent right heart catheterization fails to capture dynamic changes in mean pulmonary artery pressure (mPAP) during recovery.
Recommended action
Humanexa recommends Monitor: Monitoring the results of the CTEPH-CardioMEMS study is essential as it may lead to significant changes in clinical practice and treatment protocols. Understanding the feasibility and clinical utility of continuous monitoring will help anticipate shifts in the competitive landscape and inform strategic decisions regarding investments and partnerships in this therapeutic area.
Analysis
Monitor results on the feasibility and clinical utility of CardioMEMS™ in postoperative settings, as well as any changes in standard care practices for CTEPH.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.